VetSheet

Finasteride

4-azasteroid synthetic compound

5-alpha-reductase inhibitorPODogsFerrets

Also known as: Proscar · Propecia · finasteridum · MK-0906 · MK-906

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

0.1-0.5 mg/kgPO· once daily
🐕

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

🌎 NA — North America🌍 EU — Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Benign prostatic hyperplasia0.1-0.5 mg/kgPOonce daily🌎 NA
Benign prostatic hyperplasia<15 kg: 1.5 mg (approx. 1/3 of a 5 mg tablet); 15-30 kg: 2.5 mg (1/2 tablet); >30 kg: 5 mg (one tablet)POdaily🌎 NA
Benign prostatic hypertrophy5 mg per dogPOq24hExtended treatment course (<8 weeks) may be required for full efficacy🌍 EU
  • Benign prostatic hyperplasia: for a 10-50 kg dog, one 5 mg tablet daily
  • Benign prostatic hypertrophy: Alternative to castration. Use when delmadinone or osaterone are not appropriate.

Ferrets

IndicationDoseRouteFrequencyDurationRegion
Adjunctive treatment of adrenal disease5 mg (total dose)POonce daily🌎 NA
  • Adjunctive treatment of adrenal disease: tablet

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Finasteride is a synthetic 4-azasteroid compound that acts as a competitive and specific inhibitor of 5-alpha-reductase.

In veterinary medicine, it is primarily utilized for the medical management of ​benign prostatic hyperplasia (BPH)​ in intact male dogs. It offers a highly effective alternative to surgical castration, particularly for valuable breeding studs, as it reduces prostate size without significantly impacting fertility or circulating testosterone levels.

Additionally, finasteride is used off-label as an adjunctive therapy for adrenal disease in ferrets, helping to manage androgen-driven clinical signs such as prostatic enlargement and urinary blockages in affected males.

Mechanism of action

Finasteride specifically and totally inhibits the intracellular enzyme 5-alpha-reductase (predominantly Type II).

  • Pathway: Testosterone → (via 5-alpha-reductase) → ​Dihydrotestosterone (DHT)​

DHT is a highly potent androgen and is the primary hormone responsible for the development and enlargement of the prostate gland. By blocking this conversion, finasteride significantly reduces DHT concentrations in the prostate, liver, and skin. This leads to prostatic involution and a reduction in clinical signs of BPH. Because it does not directly block testosterone or its receptors, normal testosterone-dependent functions (such as spermatogenesis and libido) are largely preserved.

Safety & warnings

Contraindications

  • Hypersensitivity to finasteride
  • Sexually developing animals
  • Females (especially pregnant females)
  • Sexually-developing dogs
  • Breeding dogs (due to secretion in semen and teratogenic potential)

Adverse effects

  • Decreased libido
  • Decreased ejaculate volume
  • Impotence (rare/mild)
  • Secreted into semen
  • Causes fetal anomalies (teratogenic)

Precautions

WARNING: Finasteride is highly teratogenic. Pregnant women or women who may become pregnant must exercise extreme caution.

  • Hepatic Impairment: Use with caution in patients with significant hepatic impairment as metabolism of the drug may be reduced.
  • Patient Selection: Finasteride should be used in adult males only; do not use in sexually developing animals.
  • Females: Not indicated for use in females. FDA Category X for use during pregnancy in humans (demonstrates fetal abnormalities).

Drug interactions

Anticholinergic drugs

May precipitate or aggravate urinary retention thereby negating the effects of the drug when used for BPH

Monitoring

  • Prostate exam (to evaluate efficacy and reduction in size)
  • Prostate size (via palpation or ultrasound)
  • Resolution of clinical signs (e.g., tenesmus, dysuria, hematuria)

Pharmacokinetics

Half-life

Dogsapprox. 6 hours (extrapolated from human data)

Absorption

Absorbed after oral administration; in humans about 65% is bioavailable. The presence of food does not affect absorption.

Distribution

Distributed across the blood-brain barrier and is found in seminal fluid. In humans, about 90% is bound to plasma proteins.

Metabolism

Metabolized in the liver.

Elimination

Metabolites are excreted in the urine and feces. In humans, a single daily dose suppresses DHT concentrations for 24 hours.

Overdose

Limited information is available regarding acute toxicity. Mild gastrointestinal effects (such as vomiting or diarrhea) may be noted in the event of an overdose. Supportive care is recommended.

Available products

Formulations

  • Oral tablets
  • Oral: 5 mg tablet

Human-labeled

  • Finasteride Oral Tablets: 1 mg & 5 mg; Proscar®, Propecia® (Merck); generic
  • Proscar 5 mg tablets

Regulatory status

European Union✗ Not approvedPrescription onlyEMA

Not authorized for veterinary use. Should only be used under the cascade when delmadinone or osaterone are not appropriate.

United Kingdom✗ Not approvedPrescription onlyVMD

POM (Prescription Only Medicine). Not authorized for veterinary use; cascade use only.

No regulatory data for: 🇺🇸 US · 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

Storage & stability

Store tablets below 30°C in tight containers and protected from light.

Client information

CRITICAL WARNING FOR PREGNANT WOMEN: Women who are pregnant or may become pregnant must NOT handle crushed or broken tablets. The active ingredient can be absorbed through the skin and cause severe birth defects in male fetuses.

  • Patience is Key: Therapy might be prolonged (several weeks to months) before noticeable efficacy can be determined. Regular dosing compliance is mandatory for success.
  • Lifelong Commitment: Once the drug is stopped, the prostate will typically start growing again. Long-term therapy is usually required unless the dog is neutered.
  • Breeding: This medication is often chosen because it generally preserves fertility and breeding ability in stud dogs, though minor decreases in ejaculate volume may occur.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.